Editors' ChoiceNeuroscience

New connections: Treating fragile X syndrome

See allHide authors and affiliations

Sci. Signal.  02 May 2017:
Vol. 10, Issue 477, eaan5441
DOI: 10.1126/scisignal.aan5441

You are currently viewing the abstract.

View Full Text

An in vivo drug screen can identify inhibitors of the signaling pathway that is activated in fragile X syndrome.

View Full Text